TS Financial Group (TSFG)’s Anavex Life Sciences AVXL Stock Holding History

TS Financial Group (TSFG)’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	30	–	–	﹤0.01%	847
2026 Q1	$0	Hold	30	–	–	﹤0.01%	815
2025 Q4	$0	Hold	30	–	–	﹤0.01%	811
2025 Q3	$0	Hold	30	–	–	﹤0.01%	824
2025 Q2	$0	Hold	30	–	–	﹤0.01%	800
2025 Q1	$0	Hold	30	–	–	﹤0.01%	798
2024 Q4	$0	Hold	30	–	–	﹤0.01%	741
2024 Q3	$0	Hold	30	–	–	﹤0.01%	771
2024 Q2	$0	Hold	30	–	–	﹤0.01%	757
2024 Q1	$0	Hold	30	–	–	﹤0.01%	765
2023 Q4	$0	Hold	30	–	–	﹤0.01%	884
2023 Q3	$1K	Hold	30	–	–	﹤0.01%	884
2023 Q2	$0	Hold	30	–	–	﹤0.01%	988
2023 Q1	$0	Hold	30	–	–	﹤0.01%	956
2022 Q4	$0	Hold	30	–	–	﹤0.01%	971
2022 Q3	$0	Hold	30	–	–	﹤0.01%	953
2022 Q2	$0	Hold	30	–	–	﹤0.01%	978
2022 Q1	$0	Hold	30	–	–	﹤0.01%	913
2021 Q4	$1K	Hold	30	–	–	﹤0.01%	802
2021 Q3	$1K	Hold	30	–	–	﹤0.01%	785
2021 Q2	$1K	Hold	30	–	–	﹤0.01%	785
2021 Q1	$0	Buy	+30	New	+$328	﹤0.01%	761

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TS Financial Group (TSFG)'s AVXL Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 30 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #847.

TS Financial Group (TSFG) first reported a position in AVXL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1K in Q3 2023. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

TS Financial Group (TSFG) held 30 shares of Anavex Life Sciences worth $0 as of Q2 2026.
TS Financial Group (TSFG) left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #847 holding.
TS Financial Group (TSFG) first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 22 quarters since.
TS Financial Group (TSFG)'s Anavex Life Sciences position peaked at $1K in Q3 2023.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.